Mustafa Diken

6PUBLICATIONS
35CO-AUTHORS
BiomaterialsPredictive and prognostic markersInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 12, 2026
mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent models.

|May 19, 2026
The MYB-related transcription factor MYPOP acts as a selective regulator of cancer cell growth.

|Feb 13, 2025
Intralymphatic Administration of Naked mRNA Induces Allergen-Specific IgG, Promotes Th1 Responses and Reduces Anaphylactic Potential.

Marta Paolucci, Frida A M Nilsson, Agathe Duda

|Jun 17, 2024
RNA-encoded Interleukin 2 with Extended Bioavailability Amplifies RNA Vaccine-Induced Antitumor T-cell Immunity.

Daniel Peters, Lena M Kranz, David Eisel

|Aug 26, 2023
Polysarcosine-Functionalized mRNA Lipid Nanoparticles Tailored for Immunotherapy.

Christoph Wilhelmy, Isabell Sofia Keil, Lukas Uebbing

|Jul 06, 2023
The landscape of T cell antigens for cancer immunotherapy.

Aviyah Peri, Nadja Salomon, Yochai Wolf

Pageof 1

Frequent Collaborators

2 joint publications

Ugur Sahin

1 joint publications

Nadja Salomon

1 joint publications

Yochai Wolf

1 joint publications

Yardena Samuels